Pasithea Therapeutics Corp

NASDAQ:KTTA  
0.90
-0.01 (-0.62%)
Earnings Announcements

Pasithea Therapeutics Announces Financial And Business Results For The Fourth Quarter

Published: 03/30/2022 20:26 GMT
Pasithea Therapeutics Corp (KTTA) - Pasithea Therapeutics Announces Financial and Business Results for the Fourth Quarter and Full Year 2021 and Business Update for 2022.
Pasithea Therapeutics Corp - Cash Balance of $52.9 Million to Fund Operations Well Into 2024.
Revenue is expected to be $0.3 Million
Adjusted EPS is expected to be -$0.02

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.01

More details on our Analysts Page.